The refractory glaucomas;Actualités sur les glaucomes réfractaires

Journal Francais d'Ophtalmologie

Volumn 26, Issue SPEC. ISS. 2, 2003, Pages

  Valtot, F ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

Antimetabolites; Diode laser cycrophotocoagulation; Filtration surgery; Refractory glaucoma; Tube; Valve

Indexed keywords

ANTIMETABOLITE; FLUOROURACIL; MITOMYCIN C;

AQUEOUS HUMOR; CONFERENCE PAPER; DIODE LASER; ENDOSCOPIC SURGERY; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; INTRAOPERATIVE PERIOD; LASER COAGULATION; SURGICAL DRAINAGE; TREATMENT FAILURE; POSTOPERATIVE CARE; REVIEW;

GLAUCOMA; HUMANS; POSTOPERATIVE CARE; TREATMENT FAILURE;

EID: 17944388436     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Khaw PT, Chang L, Wong TTL, Mead A, Daniels JT, Cordeiro MF. Modulation of wound healing after glaucoma surgery. Cur Opin Ophthalmol, 2001;122:143-8.
2. Membrey WL, Poinoosawmy DP, Bunce C et al. Glaucoma surgery with and without adjunctive antiproliferatives in normal tension glaucoma. Intraocular pressure control and complications. Br J Ophthalmol, 2000;1984:586-90.
3. Wilkins MR, Occleston NL, Kotecha A et al. Sponge delivery variables and tissue levels of 5 fluorouracil. Br J Ophthalmol, 1999;1984:92-7.
4. Vass C, Georgopoulos M, El Menyawi et al. Intrascleral concentration vs depth profile of mitomycin-C after episcleral application: impact of applied concentration and volume of mitomycin-C solution. Exp Eye Res, 2000;1970:571-5.
5. El Sayyad F, Belmekki M, Helal M et al. Simultaneous subconjunctival and subscleral mitomycin C application in trabeculectomy. Ophthalmology, 2000;107:298-301.
6. Hitchings RA. Tube Implants. Their Development and Role in Glaucoma care. The Refractory Glaucomas, 1995; Igaku-Shoin Medical Publishers: 200-6.
7. Luttrull JK, Avery RL, Baerveldt G, Easley KA. Initial experience with pneumatically stented Baerveldt implant modified for pars plana insertion for complicated glaucoma. Ophthalmology, 2000; 107:143-50.
8. Lavin MJ, Franks WA, Wormald RP et al. Clinical risk factors for failure in glaucoma tube surgery. Arch Ophthalmol, 1992;110: 480-5.
9. 2 Baerveldt implant-longer term results. Ophthalmology, 1999;106:2312-8.
10. Broadway DC, Lester M, Schulzer M, Douglas CR. Br J Ophthalmol, 2001;85:689-95.
11. Fuller JR, Bevin TH, Molteno ACB. Long term follow-up of traumatic glaucoma treated with Molteno implants. Ophthalmology, 2001;108:1796-800.
12. Molteno ACB, Bevin TH, Herbison P, Houliston MJ. Otago glaucoma surgery outcome study: long term follow-up of cases of primary glaucoma with additional risk factors drained by Molteno implants. Ophthalmology, 2001;108:2193-200.
13. Bartamian M, Higginbotham EJ. What is the horizon for cycloablation? Cur Opin Ophthalmol, 2001;12:119-23.
14. Walland MJ, McKielvie PA. Diode laser cyclophotocoagulation histopathology in two cases of clinical failure. Ophthalmic Surg Lasers, 1998;29:852-6.
15. Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Diode laser ciliary ablation study group: long term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. Ophthalmology, 1996;103:1294-302.
16. Bloom PA, Tsai JC, Sharma K et al. Cyclodiode transscleral diode laser cyctophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology, 1997;104:1508-20.
17. Kirwan JF, Shah P, Khaw PT. Diode laser cyclophotocoagulation in the management of refractory pediatric glaucoma. Ophthalmology, 2002;109:316-23.
18. Uram M. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology, 1992;99:1823-8.
19. Topouzis F, Yu F, Coleman AL. Factors associated with elevated rates of adverse outcome after cyclodestructive procedures versus drainage device procedures. Ophthalmology, 1998;105:2276-81.